NCT05151666

Brief Summary

The purpose of the proposed clinical trial is to support intradialytic pedal cycling exercise as an intervention and show its effect on depression and how there is a need for more programs to support this. This is an exploratory single arm study. These patients will be cycling during dialysis treatment by using a graded duration model. Even though patients on hemodialysis (HD) have an increased life span due to renal replacement therapy, exercise can have a remarkable effect on their ability to perform daily activities. Dialysis has been shown to reduce self-confidence, increase social isolation, and cause feelings of disappointment in the future. This population faces mental and psychological stress due to the disease burden. Short-term supervised cycling programs while patients are receiving dialysis have been reported to induce systematic improvements for depression and anxiety. Exercise during hemodialysis is an effective way to reduce depressive symptoms without using pharmacologic measures. Data for each patient will be collected at each dialysis treatment using a unique patient identifier. The data that will be collected include duration of exercise (intermittent or continuous), any complications during HD, vital signs while cycling every 30 minutes, and how they state they feel after cycling. The measurable outcome will be depression scores. The tool that will be used for this project is the Beck Depression Inventory (BDI). The patient will complete the BDI assessment on week 1 (pre intervention as baseline) and then on week 10 (post intervention).

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Feb 2024

Shorter than P25 for not_applicable depression

Geographic Reach
1 country

2 active sites

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 1, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 9, 2021

Completed
2.2 years until next milestone

Study Start

First participant enrolled

February 2, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 11, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 20, 2024

Completed
Last Updated

February 12, 2024

Status Verified

February 1, 2024

Enrollment Period

1 month

First QC Date

December 1, 2021

Last Update Submit

February 8, 2024

Conditions

Keywords

Hemodialysis

Outcome Measures

Primary Outcomes (1)

  • Change in Beck Depression Inventory (BDI) Score

    BDI is a 21-item self-report scale designed to measure the severity of depressive symptoms. Each item is scored 0-3. The total score range is 0-63; the higher the score, the more severe the depression. A score \> 40 indicates extreme depression.

    Week 1, Week 10

Study Arms (1)

Hemodialysis Patients

EXPERIMENTAL
Other: Sunny Health & Fitness Magnetic Mini Exercise Pedal Cycle - SF-B020026 Gray

Interventions

The intervention will be that the patient cycles in a sitting position within the first 2 hours of hemodialysis treatment for 15-60 minutes/as tolerated, either intermittent/continuous duration. - Graded duration will increase every 2 weeks. This will be supervised by a dialysis nurse as per the schedule of study assessments.

Hemodialysis Patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • greater than 18 years of age
  • male or female
  • ESKD on maintenance hemodialysis for 3 consecutive months
  • adequate dialysis clearances (Kt/V greater than 1.2),
  • able to participate in exercise program based on nephrologist evaluation
  • able to provide written informed consent for participation,
  • Compliance with dialysis treatment regimen (attended 75% of ordered dialysis treatments in the last 3 months.

You may not qualify if:

  • less than 18 years old
  • on hemodialysis for \< 3 consecutive months
  • acute Kidney Injury diagnosis
  • patients deemed clinically unstable by Nephrologist
  • active foot ulcer
  • unable to provide written consent
  • refusal of participation
  • lower limb amputations
  • patients with dementia or severe cognitive impairment
  • patients with Psychiatric disorders (who are not treated and unstable)
  • pregnancy
  • myocardial infarction in the last 6 months
  • uncontrolled diabetes
  • patients on chronic Midodrine therapy for intradialytic blood pressure support.
  • deep vein thrombosis
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

NYU Dialysis Center of Bethpage

Bethpage, New York, 11714, United States

Location

NYU Winthrop Dialysis Center - Outpatient

Mineola, New York, 11501, United States

Location

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Study Officials

  • Naveed Masani, MD

    NYU Langone Health

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: Single arm pre-post intervention study design
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 1, 2021

First Posted

December 9, 2021

Study Start

February 2, 2024

Primary Completion

March 11, 2024

Study Completion

May 20, 2024

Last Updated

February 12, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices) will be shared upon reasonable request.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.
Access Criteria
The investigator who proposed to use the data will have access to the data upon reasonable request. Requests should be directed to Naveed.Masani@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.

Locations